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Hepatocellular carcinomaTo assess the potential competitive endogenous RNA (ceRNA) network in hepatocellular cancer (HCC), the
lncRNA, mRNA, and microRNA microarrays were conducted on 3 pairs of HCC and paired normal liver tissue.
After that, the arrays were normalized and analyzed with gene oncology (GO) and pathway analysis. Next, we
screened out the pseudogenes and their cognate protein coding genes which are both down-regulated in HCC.
Finally, the up-regulated microRNA binding sites were predicted on the most down-regulated pseudogene and
its cognate protein-coding gene. All the array data were uploaded to Gene Expression Omnibus (accession num-
ber GSE64633).
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).SpeciﬁcationsOrganism cell
line/tissueHomo sapiensSex Male or female
Sequencer or array
typeArraystar Human LncRNA Microarray V2.0, miRCURY™ LNA
Array (v.18.0)Data format Raw data: TXT. SOFT. MINiNAL. ﬁle
Experimental
factorsTumor vs. normal liver tissue in humansExperimental
featuresUse whole genome microarray to predict the ceRNA
network in HCCConsent All patients gave their written informed consent before
study entry.Sample source
locationGuangzhou, ChinaDirect link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE64633.sive Cancer Center, The Johns
1@jhmi.edu (F.M. Selaru).
. This is an open access article underExperimental design, materials and methods
Human tissues
After informed consent was given and under the Institutional
Review Board approval, human HCC and paired normal liver tissues
were obtained immediately after surgery at the Johns Hopkins Hospital
(Baltimore, US), The 3rd Afﬁliated Hospital of Sun Yat-sen University
(Guangzhou, China), Fundeni Clinical Institute (Bucharest, Romania),
and Ion Chiricuta Comprehensive Cancer Center (Clui Nanoca,
Romania). Tissues were snap frozen upon acquisition and stored in a
−80 °C freezer until use.LncRNA, mRNA labeling and array hybridization
The Arraystar Human lncRNA Array v2.0 was used to proﬁle both
lncRNAs and messenger RNAs (mRNAs) in human genome of 3 pairs of
human HCC and the matched normal tissues. 33,045 LncRNAs were col-
lected from the authoritative data sources including RefSeq, UCSC
KnownGenes, Ensembl and many related literatures. Sample labeling
and array hybridization were performed according to the Agilent One-
Color Microarray-Based Gene Expression Analysis protocol (Agilent
Technology) with minor modiﬁcations. Brieﬂy, mRNA was puriﬁed from
1 μg total RNA after the removal of rRNA (mRNA-ONLY™ Eukaryoticthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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transcribed into ﬂuorescent cRNA along the entire length of the
transcripts without 3′ bias utilizing a random priming method. The
labeled cRNAs were puriﬁed by the RNAeasy Mini Kit (Qiagen). The con-
centration and speciﬁc activity of the labeled cRNAs (pmol Cy3/μg cRNA)
weremeasured by usingNanoDropND-1000. 1 μg of each labeled cRNA is
fragmented by adding 11 μl 10 × Blocking Agent and 2.2 μl of
25 × Fragmentation Buffer, and then heated the mixture at 60 °C for
30 min; ﬁnally 55 μl 2 × GE Hybridization Buffer is added to dilute the
labeled cRNA. 100 μl of hybridization solution was dispensed into the
gasket slide and assembled to the lncRNA expression microarray slide.
The slides were incubated for 17 h at 65 °C in an Agilent hybridization
oven. The hybridized arrays were washed, ﬁxed and scanned by using
the Agilent DNA Microarray Scanner (part number G2505B).
MicroRNA labeling and array hybridization
MiRCURY™ Hy3™/Hy5™ Power labeling kit (Exiqon) was used
according to the manufacturer's guideline for miR labeling of the same
3 pairs of HCC and matched normal liver tissues. 1.0 mg of each sample
was 3′-end-labeled with Hy3™ ﬂuorescent label using T4 RNA ligase by
the following procedure: RNA in 2.0 μl of water was combined with
1.0 μl of CIP buffer and CIP (Exiqon). The mixture was incubated for
30 min at 37 °C, and was terminated by incubation for 5 min at 95 °C.
Then 3.0 μl of labeling buffer, 1.5 μl of ﬂuorescent label (Hy3™), 2.0 μl
of DMSO, and 2.0 μl of labeling enzyme were added into the mixture.
The labeling reaction was incubated for 1 h at 16 °C, and terminated
by incubation for 15min at 65 °C. After stopping the labeling procedure,
the Hy3™-labeled samples were hybridized on the miRCURY™ LNA
Array (v.18.0) (Exiqon) according to the array manual. The total 25 μl
mixture from Hy3™-labeled samples with 25 μl hybridization buffer
was ﬁrst denatured for 2 min at 95 °C, incubated on ice for 2 min and
then hybridized to the microarray for 16–20 h at 56 °C in a 12-Bay
Hybridization Systems (Hybridization System–Nimblegen Systems),
which provides an active mixing action and constant incubation
temperature to improve hybridization uniformity and enhance signal.Fig. 1.Working hypothesis postulates that INTS6, INTS6P1 and miR-17-5p are part of same reg
impacts the levels of INTS6 (Step 3). Decreasing levels of INTS6P1 (red arrow) results in increas
INTS6. Increasing levels of INTS6P1 (green arrow) results in decreasing levels of miR-17-5p wiFollowing hybridization, the slides were achieved, washed several
times usingWash buffer kit (Exiqon), and ﬁnally dried by centrifugation
for 5 min at 400 rpm. Then the slides were scanned using the Axon
GenePix 4000B microarray scanner (Axon Instruments).
Data analysis
Agilent Feature Extraction software (version 10.7.3.1) was used to
analyze lncRNA and mRNA array images. Quantile normalization and
subsequent data processing were performed by using the GeneSpring
GX v11.5.1 software package (Agilent Technologies). After quantile
normalization of the raw data, LncRNAs and mRNAs that at least 1 out
of 6 samples have ﬂags in Present or Marginal were chosen for further
data analysis. Differentially expressed LncRNAs and mRNAs with
statistical signiﬁcance were identiﬁed through Volcano Plot ﬁltering.
Hierarchical Clustering was performed using the Agilent GeneSpring
GX software (version 11.5.1). GO analysis and Pathway analysis were
performed by using the standard enrichment computation method.
FormicroRNA array analysis, the scanned images were then imported
into GenePix Pro 6.0 software (Axon) for grid alignment and data extrac-
tion. ReplicatedmiRNAswere averaged andmiRNAs that intensities≥ 50
in all sampleswere chosen for calculating normalization factor. Expressed
data were normalized using the Median normalization. After normaliza-
tion, signiﬁcantly differentially expressed miRNAs were identiﬁed
through Volcano Plot ﬁltering. Hierarchical clustering was performed
using MEV software (v4.6, TIGR).
Discussion
According to the ceRNAparadigm, longnon-coding transcripts share
miR responsive elements (MREs) with protein-coding genes, and
compete with these protein-coding genes for the pool of shared miRs
[1]. Thus, ceRNA would play a crucial role in the regulation of their
cognate genes [2–4]. Here, we described a dataset composed of lncRNA,
mRNA andmicroRNAmicroarray gene expression proﬁling for HCC and
normal liver tissue. With this dataset, we were able to ﬁnd out someulatory circuit. INTS6P1 levels (Step 1), through modulation of miR-17-5p levels (Step 2)
ing levels of miR-17-5p (blue bar) with subsequent decreasing levels of tumor suppressor
th subsequent increasing levels of tumor suppressor INTS6.
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dataset would be particularly valuable for investigating the interplay
among lncRNA, mRNA, and microRNA in HCC. For example, we have
found that INTS6P1 and INTS6 are part of the same competitive tumor
suppressor network that includes oncomiR-17-5p (Fig. 1). This ﬁnding
provides a new insight in understanding the underlying mechanisms
of hepatocarcinogenesis and uncovers the potential therapeutic targets.
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